This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1973 Oct 27;2(7835):929-31.

doi: 10.1016/s0140-6736(73)92595-6.

Sustained levodopa therapy in parkinsonism

K R Hunter, K M Shaw, D R Laurence, G M Stern

PMID: 4126558
DOI: 10.1016/s0140-6736(73)92595-6

Sustained levodopa therapy in parkinsonism

K R Hunter et al. Lancet. 1973.

. 1973 Oct 27;2(7835):929-31.

doi: 10.1016/s0140-6736(73)92595-6.

Authors

K R Hunter, K M Shaw, D R Laurence, G M Stern

PMID: 4126558
DOI: 10.1016/s0140-6736(73)92595-6

No abstract available

PubMed Disclaimer

Similar articles

Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
Godwin-Austen RB, Bergmann S, Frears CC. Godwin-Austen RB, et al. Br Med J. 1971 Nov 27;4(5786):522-4. doi: 10.1136/bmj.4.5786.522. Br Med J. 1971. PMID: 4942463 Free PMC article. Clinical Trial.
L-Dopa in the treatment of parkinsonism.
Calne DB. Calne DB. Clin Pharmacol Ther. 1970 Nov-Dec;11(6):789-801. doi: 10.1002/cpt1970116789. Clin Pharmacol Ther. 1970. PMID: 4921292 Review. No abstract available.
Treatment of parkinsonism with levodopa.
Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Yahr MD, et al. Arch Neurol. 1969 Oct;21(4):343-54. doi: 10.1001/archneur.1969.00480160015001. Arch Neurol. 1969. PMID: 5820999 No abstract available.
Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.
Fehling C. Fehling C. Z Neurol. 1972;202(3):197-208. doi: 10.1007/BF00316221. Z Neurol. 1972. PMID: 4120049 No abstract available.
Levodopa in Parkinsonism.
Weiss JL, Chase TN. Weiss JL, et al. Drugs. 1971;2(4):257-61. doi: 10.2165/00003495-197102040-00001. Drugs. 1971. PMID: 4948349 Review. No abstract available.

See all similar articles

Cited by

Cerebral atrophy and long-term response to levodopa in Parkinson's disease.
Schneider E, Fischer PA, Jacobi P, Becker H, Beyer M. Schneider E, et al. J Neurol. 1979;222(1):37-43. doi: 10.1007/BF00313265. J Neurol. 1979. PMID: 93625
Bromocriptine in Parkinsonism.
Pearce I, Pearce JM. Pearce I, et al. Br Med J. 1978 May 27;1(6124):1402-4. doi: 10.1136/bmj.1.6124.1402. Br Med J. 1978. PMID: 348261 Free PMC article. Review.
Levodopa: long-term impact on Parkinson's disease.
[No authors listed] [No authors listed] Br Med J (Clin Res Ed). 1981 Feb 7;282(6262):417-8. doi: 10.1136/bmj.282.6262.417. Br Med J (Clin Res Ed). 1981. PMID: 6780051 Free PMC article. No abstract available.
Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
Melamed E, Hefti F, Wurtman RJ. Melamed E, et al. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4305-9. doi: 10.1073/pnas.77.7.4305. Proc Natl Acad Sci U S A. 1980. PMID: 6254020 Free PMC article.
Parkinson's disease and levodopa. A five-year follow-up and review.
Markham CH, Treciokas LJ, Diamond SG. Markham CH, et al. West J Med. 1974 Sep;121(3):188-206. West J Med. 1974. PMID: 4606887 Free PMC article. Review. No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science